샘플 요청 목록

 카트 문의
시장보고서
상품코드
1655462

세계의 이식형 약물전달 디바이스 시장

Implantable Drug Delivery Devices
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 196 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 이식형 약물전달 디바이스 시장은 2030년까지 미국에서 412억 달러에 달할 전망

2024년에 289억 달러로 추정되는 세계의 이식형 약물전달 디바이스 시장은 2024-2030년에 CAGR 6.1%로 성장하며, 2030년에는 412억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 피임용 임플란트는 CAGR 6.3%를 기록하며, 분석 기간 종료시에는 98억 달러에 달할 것으로 예측됩니다. 척추 임플란트 분야의 성장률은 분석 기간 중 CAGR 5.7%로 추정됩니다.

미국 시장은 80억 달러로 추정, 중국은 CAGR 5.7%로 성장 예측

미국의 이식형 약물전달 디바이스 시장은 2024년에 80억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 64억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 5.7%입니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 5.8%와 4.9%로 예측됩니다. 유럽에서는 독일이 CAGR 5.1%로 성장할 것으로 예측됩니다.

세계의 이식형 약물전달 디바이스 시장 - 주요 동향과 촉진요인 정리

이식형 약물전달 장비란 무엇이며, 왜 의료에 변화를 초래하는가?

이식형 약물전달 장비는 체내의 특정 부위에 직접적으로 표적화된 장기적인 약물 방출을 위해 설계된 특수한 의료용 임플란트입니다. 이 장비는 특히 암, 당뇨병, 심혈관 질환과 같은 만성질환에 대해 일관되고 정확한 치료 요법을 가능케 함으로써 의료계에 변화를 가져다 줄 수 있습니다. 흡수율이 일정하지 않은 경구 및 주사제와는 달리, 이식형 디바이스는 일관된 약물 투여를 보장하고 치료 효과를 향상시키며 부작용을 줄입니다. 소화기관을 우회하여 표적 조직에 직접 약물을 전달함으로써 복잡한 질환에 보다 효과적인 솔루션을 제공하며, 정확한 투여가 중요한 종양학 및 내분비학 분야에서 특히 유용하게 사용될 수 있습니다.

기술의 발전은 어떻게 이식형 약물전달 시장을 형성하고 있는가?

생체 재료, 마이크로 전자공학 및 생명공학의 발전으로 이식형 약물전달 장비의 기능, 내구성 및 안전성이 크게 향상되고 있습니다. 최신 장비는 현재 생체 내에서 쉽게 분해되지 않는 생체 적합성 재료로 만들어져 장기적인 효능을 보장하고 잦은 교체 필요성을 줄입니다. 무선 제어 및 마이크로펌프 기술과 같은 혁신은 프로그램 가능하고 조절 가능한 약물 방출을 가능하게 하여 의료 프로바이더가 환자의 상태 변화에 따라 용량을 조정할 수 있도록 합니다. 또한 최근에는 약물전달을 실시간으로 모니터링할 수 있는 센서와 커넥티비티가 내장된 기기들이 등장해 적시에 조정하고 환자 결과를 개선할 수 있게 되었습니다. 이러한 기술적 도약으로 인해 이식형 기기의 적용 범위가 넓어지고, 다양한 복잡한 건강 상태의 치료에 고도로 적응할 수 있게 되었습니다.

왜 이식형 약물전달 장비가 일반화되는가?

만성질환과 생활습관병 증가와 고령화로 인해 보다 효율적이고 덜 침습적인 치료법에 대한 요구가 증가함에 따라 이식형 약물전달 장비는 현대 의료 분야에서 더욱 보편화되고 있습니다. 환자와 의료진은 잦은 병원 방문의 필요성을 없애고 처방된 요법을 더 잘 준수할 수 있도록 도와주는 이러한 기기의 편리함과 신뢰성에 점점 더 매력을 느끼고 있습니다. 또한 최소침습 수술 기술의 발전으로 이식 과정이 더 빠르고 통증이 적어지면서 보급이 더욱 가속화되고 있습니다. 이러한 장기적이고 지속적인 약물 투여로의 전환은 효과적인 질병 관리를 보장하면서 환자의 삶의 질을 향상시키는 데 초점을 맞춘 헬스케어의 큰 흐름을 반영하고 있습니다.

임플란트 약물전달 장비 시장의 성장은 몇 가지 요인에 의해 촉진

임플란트 약물전달 장비 시장의 성장은 급속한 기술 발전, 만성질환의 유병률 증가, 맞춤형 의료에 대한 관심 증가 등 여러 가지 요인에 의해 주도되고 있습니다. 생체 재료 및 소형화 기술의 혁신으로 인해 신뢰할 수 있고 제어된 약물 방출을 제공하는 내구성 있는 소형 디바이스의 개발이 가능해지면서 암, 호르몬 불균형, 신경질환 등 다양한 질환에 대한 적용이 확대되고 있습니다. 표적 치료와 약물 생체 이용률 향상에 대한 수요가 증가하면서, 특히 헬스케어 분야에서 환자 중심의 정밀 치료로 전환하는 추세에 따라 이러한 기기의 채택이 가속화되고 있습니다. 또한 신흥 시장의 의료 인프라 확대와 세계 헬스케어 지출 증가는 이러한 첨단 기기의 도입 기회를 증가시켜 시장 성장을 더욱 촉진하고 있습니다.

부문

용도(피임, 안과, 심장혈관, 당뇨병, 종양, 자가면역질환, 기타 용도), 제품 유형(피임 임플란트, 척추 임플란트, 근접치료 시드, 약제용출스텐트, 생체흡수성 스텐트, 안내 임플란트, 주입 펌프, 기타 제품 유형), 기술(확산, 침투압, 자기, 기타 기술), 유형(생분해성, 비생분해성)

조사 대상 기업의 예(총 46건)

  • Abbott Laboratories
  • Allergan PLC
  • Bausch and Lomb, Inc.
  • Bayer AG
  • Boston Scientific Corporation
  • Medtronic PLC
  • Merck & Co., Inc.
  • Teleflex, Inc.
  • Varian Medical Systems, Inc.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장의 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

KSA 25.02.28

Global Implantable Drug Delivery Devices Market to Reach US$41.2 Billion by 2030

The global market for Implantable Drug Delivery Devices estimated at US$28.9 Billion in the year 2024, is expected to reach US$41.2 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Contraceptive Implants, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$9.8 Billion by the end of the analysis period. Growth in the Spinal Implants segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.0 Billion While China is Forecast to Grow at 5.7% CAGR

The Implantable Drug Delivery Devices market in the U.S. is estimated at US$8.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.4 Billion by the year 2030 trailing a CAGR of 5.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.8% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Global Implantable Drug Delivery Devices Market - Key Trends & Drivers Summarized

What Are Implantable Drug Delivery Devices and Why Are They Transformative in Medicine?

Implantable drug delivery devices are specialized medical implants designed to provide targeted, controlled, and long-term drug release directly to specific areas within the body. These devices represent a transformative advancement in medicine, enabling treatment regimens that are both consistent and precise, particularly for chronic conditions like cancer, diabetes, and cardiovascular diseases. Unlike oral or injectable medications, which can vary in absorption rates, implantable devices ensure consistent drug dosing, improving treatment efficacy and reducing side effects. By bypassing the digestive system and delivering medication directly to target tissues, these devices offer a more effective solution for complex medical conditions, which is especially beneficial in oncology and endocrinology, where precise dosing is critical.

How Are Technological Advancements Shaping the Implantable Drug Delivery Market?

Advancements in biomaterials, microelectronics, and biotechnology have significantly enhanced the functionality, durability, and safety of implantable drug delivery devices. Modern devices are now made from biocompatible materials that resist degradation in the body, ensuring long-term efficacy and reducing the need for frequent replacements. Innovations such as wireless control and micro-pump technologies allow for programmable and adjustable drug release, enabling healthcare providers to tailor dosages based on a patient's evolving condition. Furthermore, some devices now incorporate sensors and connectivity features that enable real-time monitoring of drug delivery, allowing for timely adjustments and better patient outcomes. These technological breakthroughs are broadening the scope of implantable devices, making them highly adaptable for treating a range of complex health conditions.

Why Are Implantable Drug Delivery Devices Becoming More Commonplace?

The increasing prevalence of chronic and lifestyle-related diseases, along with a growing aging population, has driven demand for more efficient, less invasive treatment options, making implantable drug delivery devices more commonplace in modern healthcare. Patients and healthcare providers are increasingly drawn to the convenience and reliability of these devices, which eliminate the need for frequent hospital visits and enhance patient adherence to prescribed regimens. Additionally, advances in minimally invasive surgical techniques have made the implantation process quicker and less painful, further encouraging adoption. This shift toward long-term, continuous medication delivery reflects a larger trend in healthcare focused on improving patient quality of life while ensuring effective disease management.

The Growth in the Implantable Drug Delivery Devices Market Is Driven by Several Factors

The growth in the implantable drug delivery devices market is driven by several factors, including rapid technological advancements, rising prevalence of chronic diseases, and an increased focus on personalized medicine. Innovations in biomaterials and miniaturization technologies have allowed for the development of durable, compact devices that provide reliable, controlled drug release, expanding the application of these devices to conditions like cancer, hormonal imbalances, and neurological disorders. Growing demand for targeted therapies and improved drug bioavailability has fueled the adoption of these devices, particularly as healthcare shifts toward patient-centered, precision treatment. Additionally, the expansion of healthcare infrastructure in emerging markets and increased healthcare spending globally are creating more opportunities for the adoption of these advanced devices, further supporting market growth.

SCOPE OF STUDY:

The report analyzes the Implantable Drug Delivery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases, Other Applications); Product Type (Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps, Other Product Types); Technology (Diffusion, Osmotic, Magnetic, Other Technologies); Type (Biodegradable, Non-biodegradable)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 46 Featured) -

  • Abbott Laboratories
  • Allergan PLC
  • Bausch and Lomb, Inc.
  • Bayer AG
  • Boston Scientific Corporation
  • Medtronic PLC
  • Merck & Co., Inc.
  • Teleflex, Inc.
  • Varian Medical Systems, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Implantable Drug Delivery Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Targeted and Controlled Drug Release Mechanisms
    • Increased Adoption in Chronic Disease and Pain Management
    • Rising Focus on Biocompatible and Biodegradable Implantable Devices
    • Advancements in Micro- and Nano-technology for Precision Drug Delivery
    • Expansion of Implantable Drug Delivery in Oncology Treatments
    • Growth in Demand for Long-acting Implantable Devices in Diabetes Management
    • Surge in Use of Implantable Systems for Hormone Replacement Therapy
    • Demand for Minimally Invasive Implantable Drug Delivery Procedures
    • Integration of Smart Sensors for Real-time Drug Release Monitoring
    • Enhanced Patient Compliance with Sustained Release Drug Implants
    • Development of Refillable and Reusable Implantable Devices
    • Increasing Applications of Implantable Devices in Neurological Treatments
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Implantable Drug Delivery Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Implantable Drug Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Implantable Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Contraceptive Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Contraceptive Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Spinal Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Spinal Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Spinal Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Brachytherapy Seeds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Brachytherapy Seeds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Brachytherapy Seeds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Drug Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Bio-absorbable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Bio-absorbable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Bio-absorbable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Intraocular Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Intraocular Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Intraocular Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Biodegradable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Biodegradable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Biodegradable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Non-biodegradable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Non-biodegradable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Non-biodegradable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Diffusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Diffusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Diffusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Osmotic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Osmotic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Osmotic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Magnetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Magnetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Magnetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Contraception by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Contraception by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: World 15-Year Perspective for Contraception by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: World 15-Year Perspective for Ophthalmology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 53: World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: World 15-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 56: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: World 15-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 59: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 62: World Recent Past, Current & Future Analysis for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 63: World Historic Review for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: World 15-Year Perspective for Autoimmune Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 65: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 66: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 68: USA Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: USA Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: USA 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 71: USA Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: USA Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: USA 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2015, 2025 & 2030
    • TABLE 74: USA Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: USA Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: USA 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 77: USA Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: USA Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: USA 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 80: Canada Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Canada Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Canada 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 83: Canada Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Canada Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Canada 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2015, 2025 & 2030
    • TABLE 86: Canada Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Canada Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Canada 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 89: Canada Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Canada Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Canada 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 92: Japan Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Japan Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Japan 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 95: Japan Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Japan Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Japan 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2015, 2025 & 2030
    • TABLE 98: Japan Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Japan Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Japan 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 101: Japan Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Japan Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Japan 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 104: China Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: China Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: China 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 107: China Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: China Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: China 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2015, 2025 & 2030
    • TABLE 110: China Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: China Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: China 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 113: China Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: China Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: China 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 116: Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 117: Europe Historic Review for Implantable Drug Delivery Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Europe 15-Year Perspective for Implantable Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 119: Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Europe Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Europe 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 122: Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Europe Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Europe 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2015, 2025 & 2030
    • TABLE 125: Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Europe Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Europe 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 128: Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Europe Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Europe 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 131: France Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: France Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: France 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 134: France Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: France Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: France 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2015, 2025 & 2030
    • TABLE 137: France Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: France Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: France 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 140: France Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: France Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: France 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 143: Germany Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Germany Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Germany 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 146: Germany Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Germany Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Germany 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2015, 2025 & 2030
    • TABLE 149: Germany Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Germany Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Germany 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 152: Germany Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Germany Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Germany 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 155: Italy Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Italy Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Italy 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 158: Italy Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Italy Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Italy 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2015, 2025 & 2030
    • TABLE 161: Italy Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Italy Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Italy 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 164: Italy Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Italy Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Italy 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 167: UK Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: UK Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: UK 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 170: UK Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: UK Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: UK 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2015, 2025 & 2030
    • TABLE 173: UK Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: UK Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: UK 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 176: UK Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: UK Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: UK 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Europe Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Europe 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Europe Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Europe 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Europe Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Europe 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2015, 2025 & 2030
    • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Asia-Pacific Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Asia-Pacific 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Asia-Pacific Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Asia-Pacific 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 203: Rest of World Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of World Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of World 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of World Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of World Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of World 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2015, 2025 & 2030
    • TABLE 209: Rest of World Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of World Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of World 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 212: Rest of World Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of World Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Rest of World 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제